All Pharma articles – Page 25
-
HSJ PartnersHSJ webinar: the challenges of introducing new medicines to the NHS
Register to view our free webinar
-
CommentPodcast: Medicines optimisation in the new NHS
Charles Alessi and Malcolm Qualie discuss how to get the best out of the drugs budget
-
NewsDrug firms accused of pay-for-delay deal
Drugs giant GlaxoSmithKline has been accused by the competition watchdog of paying firms to delay the launch of cheaper versions of its antidepressant treatment, in a move which denied the NHS “significant” cost savings.
-
NewsSome cancer drugs taken off fast track funding list, NHS England admits
NHS England today confirmed that it had taken some cancer treatments off its “fast track” list following changes to the cancer drugs fund announced yesterday.
-
NewsHMRC investigating trusts over drug tax schemes
HM Revenue and Customs is examining hospital trusts’ tax arrangements amid a growing trend to lawfully avoid paying VAT on outpatient drugs, HSJ has learned.
-
NewsInnovators 'must provide more evidence' about product effectiveness
Pharmaceutical and technology companies looking to introduce their products into the NHS must do more research to demonstrate effectiveness, a senior NHS Commissioning Board official has said.
-
HSJ Local
SHIP cluster to save £10m through medicines management
FINANCE: The Southampton, Hampshire, Isle of Wight and Portsmouth primary care trust cluster expects to save £10.2m through medicines management this year.
-
NewsPCTs set up rebate deals despite DH opposition
At least 30 per cent of primary care trusts are defying the Department of Health to set up discount deals with pharmaceutical companies, an HSJ investigation has found.
-
NewsAnalysed: primary care rebate schemes
This week’s HSJ Briefing looks at primary care rebate schemes which, it is hoped, will lead to savings on drugs bills
-
News
ABPI to discuss NICE role in bid to break pricing deadlock
The government is to hold talks with the pharmaceutical industry on the role of the National Institute for Heath and Clinical Excellence, in a bid to reach agreement on new pricing arrangements.
-
HSJ Local
North East GPs 'prescribe paracetamol at more than twice expected rate'
FINANCE: GPs in seven North East primary care trusts are prescribing paracetamol at twice the expected rate and could save the NHS an estimated £2.5m a year by their bringing reducing to the national average, the healthcare analysis firm CHKS has said.
-
HSJ Local
Northumbria Healthcare launches care home medication project
PERFORMANCE: Northumbria Healthcare Foundation Trust has launched a team to review use of medication in case homes.
-
SupplementsRewriting the script - pharmacy roundtable special report
In autumn last year, a group of pharmacy experts gathered in London to discuss how specialist pharmacy services could evolve to benefit patients, NHS organisations and the NHS as a whole – and what role the private sector could play in this.
-
NewsNew IFR policy could 'snuff out' innovation
The NHS Commissioning Board’s plans to develop national policies for new treatments after just five individual funding requests could stifle innovation, it has been warned.
-
News
Health committee calls for swift action on value based pricing
Swift action is needed to ensure a smooth changeover to a new system of pricing for the drugs used by the NHS, the Commons health committee has said in a report today.
-
NewsGeographical variation in new drug uptake revealed
The huge disparity in uptake of medicines and technologies across the NHS has been laid bare by the first “innovation scorecard”.
-
NewsNICE to back use of Lucentis for eye condition
Thousands of people with a devastating eye condition could be offered a potentially sight-saving treatment following a U-turn by the health watchdog.
-
-
NewsMove from branded drugs could save NHS millions
Doctors could save the NHS billions of pounds a year by ditching expensive branded drugs in favour of prescribing cheaper, equally effective alternatives, new research has found.
-
News
Attention deficit drugs bill in seven-fold increase
The health service is facing a growing bill from the record number of people being given drugs to combat attention-deficit hyperactivity disorder (ADHD), figures show.